Press "Enter" to skip to content

New patent for Sunovion Pharms drug APTIOM

0
Copyright © DrugPatentWatch. Originally published at New patent for Sunovion Pharms drug APTIOM

Annual Drug Patent Expirations for APTIOM
Annual Drug Patent Expirations for APTIOM

Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug and one Paragraph IV challenge.

APTIOM drug price trends.

Drug patent litigation for APTIOM.

This drug has one hundred and thirteen patent family members in thirty countries.

The generic ingredient in APTIOM is eslicarbazepine acetate. One supplier is listed for this compound. Additional details are available on the eslicarbazepine acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Sunovion Pharms drug APTIOM
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions